News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and views
Campaigning
We want men with prostate cancer to get better diagnosis, better treatment and better support. But we can’t do it alone: we need your help.
Join the fightAbiraterone extends the lives of men like Robert, but it could be rejected for future use. We stand with him and 4,300 others to ask why.
Drug companies and NICE must put their differences aside and think of the men and families at the centre of all this.
Dr Matthew Hobbs is “doubly excited” by new precision medicines for advanced prostate cancer.
These precision drugs are the biggest breakthroughs we’ve seen in decades for extending the lives of men with advanced prostate cancer.
Bernie would be thrilled to know he’s part of raising £1 million this Christmas.
Sue McDermott talks about her husband Bernie's commitment to new research, and how Christmas is different without him around.
New evidence for world's first ever precision medicine for prostate cancer
Today, results released at the ESMO 2019 conference in Barcelona showed targeted breast and ovarian cancer drug olaparib could slow the progression of advanced prostate cancer. Find out how these advances are set to transform men’s lives.
Research blog: The jigsaw is falling into place but one crucial piece is missing
BLOG: From 'seek and destroy' radiotherapy to repurposing an ovarian cancer drug, it's been a week of big news from the world's biggest cancer research conference. Dr Matthew Hobbs gives his perspective on the latest in prostate cancer and what needs to happen next.
Quicker, stronger, personalised and targeted: the cutting edge of research into better treatments
BLOG: Dr Matthew Hobbs, our Acting Director of Research, shares his highlights from the latest research into more effective treatments for men with prostate cancer.
The oxygen-boosting precision medicine that could make radiotherapy work for more men
BLOG: Our research comms officer, Ruby Kell, explains how a promising new test we're funding could help identify men whose radiotherapy is likely to fail, then target them with a commonly-used drug that will stop the treatment from being thwarted.
"Dad would be over the moon about the new research – you need hope going up against prostate cancer"
Hayley Yarnley knows how much our new precision medicine research programme could have helped her father, Bernie, who died from advanced prostate cancer last December. She describes how the births of her children kept him going during his treatment, and why he was convinced scientists would one day find a cure.
Early research shows immunotherapy's potential for one type of aggressive prostate cancer
The Institute of Cancer Research has discovered a genetic mutation in samples of some men's tumours that could make them particularly susceptible to immunotherapy treatment. The researchers are now committed to running clinical trials to prove if their theory is right.
Ovarian cancer drug could help more men with prostate cancer than first thought
A new study suggests olaparib could boost the efficacy of treatment for earlier-stage prostate cancer, after discovering how it can block the repair of DNA in cancer cells no matter what kind of the disease they have.